Gilead Sciences: A Strong Quarter Hidden Behind Ugly Earnings (NASDAQ:GILD)
· seekingalpha.com
Gilead Sciences is upgraded to a cautious 'Buy' after Q2/26, supported by robust revenue growth and raised guidance. Read more on GILD stock here.
Gilead Sciences, Inc. ( GILD ) is one of my long‑term holdings, and it actually took several years before this investment paid off. In the last few years, I w...